Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Jonathan Cunningham, MD
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Akshay S. Desai, MD
NYHA FC and Finerenone Response: Clinical Trial Insights
John Ostrominski
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
FINE-HEART Pooled Analysis
Maria Pabon
Advances in Care for ATTR-CM: Current and Emerging Strategies
Gautam Nayak, MD
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Treating ATTR-CM: Current Strategies and Emerging Options
Frederick Ruberg, MD
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
Michelle Kittleson, MD, PhD
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Understanding the Pathophysiology Behind ATTR-CM
ATTR-CM Screening: How Economic Factors Can Impact Care
Kibum Kim, PhD
Patient Case Study: Obesity and VTE
Renato D. Lopes, MD, MHS, PhD
Alexander T. Cohen, MD, MBBS
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.